184 related articles for article (PubMed ID: 11140106)
1. [[Radioguided surgery in the treatment of gastro-entero-pancreatic neuroendocrine tumors] ].
Cirillo F; Bottini A; Lima G; Alquati P
Minerva Chir; 2000; 55(7-8):517-21. PubMed ID: 11140106
[TBL] [Abstract][Full Text] [Related]
2. [Pre- and intraoperative localization of neuroendocrine tumors].
Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe.
Benevento A; Dominioni L; Carcano G; Dionigi R
Semin Surg Oncol; 1998 Dec; 15(4):239-44. PubMed ID: 9829380
[TBL] [Abstract][Full Text] [Related]
4. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors.
Adams S; Baum RP
Q J Nucl Med; 2000 Mar; 44(1):59-67. PubMed ID: 10932602
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of somatostatin receptor scintigraphy. Studies of pre- and intraoperative localization of gastrointestinal and pancreatic tumors].
Adams S; Baum RP; Adams M; Wenisch HJ; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
Med Klin (Munich); 1997 Mar; 92(3):138-43. PubMed ID: 9173204
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative gamma probe detection of neuroendocrine tumors.
Adams S; Baum RP; Hertel A; Wenisch HJ; Staib-Sebler E; Herrmann G; Encke A; Hör G
J Nucl Med; 1998 Jul; 39(7):1155-60. PubMed ID: 9669386
[TBL] [Abstract][Full Text] [Related]
9. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome.
Grossrubatscher E; Vignati F; Dalino P; Possa M; Belloni PA; Vanzulli A; Bramerio M; Marocchi A; Rossetti O; Zurleni F; Loli P
J Endocrinol Invest; 2005 Jan; 28(1):72-8. PubMed ID: 15816375
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
[TBL] [Abstract][Full Text] [Related]
11. [Intraoperative isotope-controlled probe localization after somatostatin receptor scintigraphy of occult neuroendocrine tumors].
Runkel N; Bäder M; Wiedenmann B; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1034-7. PubMed ID: 9931782
[TBL] [Abstract][Full Text] [Related]
12. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
13. High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
Meyers MO; Anthony LB; McCarthy KE; Drouant G; Maloney TJ; Espanan GD; Woltering EA
South Med J; 2000 Aug; 93(8):809-11. PubMed ID: 10963516
[TBL] [Abstract][Full Text] [Related]
14. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
15. 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET.
Yüksel M; Eziddin S; Ladwein E; Haas S; Biersack HJ
Ann Nucl Med; 2005 Oct; 19(7):611-5. PubMed ID: 16363628
[TBL] [Abstract][Full Text] [Related]
16. Surgery for metastatic neuroendocrine tumors with occult primaries.
Bartlett EK; Roses RE; Gupta M; Shah PK; Shah KK; Zaheer S; Wachtel H; Kelz RR; Karakousis GC; Fraker DL
J Surg Res; 2013 Sep; 184(1):221-7. PubMed ID: 23643298
[TBL] [Abstract][Full Text] [Related]
17. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
[TBL] [Abstract][Full Text] [Related]
18. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
[TBL] [Abstract][Full Text] [Related]
19. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Banzo J; Abós MD; Prats E; García F; Razola P
Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
[No Abstract] [Full Text] [Related]
20. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
Nauck C; Ivancević V; Emrich D; Creutzfeldt W
Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
